Xenon Pharmaceuticals Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $199.2M | $142.7M | $148.6M | $57.2M | $175.7M | $45.0M | $24.8M | $67.8M |
| Accounts Receivable | — | $1.5M | $874.0K | $986.0K | $2.8M | $1.8M | $813.0K | $151.0K |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $560.6M | $635.3M | $645.0M | $600.3M | $559.0M | $181.8M | $144.9M | $121.3M |
| Property, Plant & Equipment | $8.7M | $10.3M | $9.7M | $6.5M | $4.5M | $3.6M | $1.7M | $991.0K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $633.2M | $798.1M | $964.8M | $754.1M | $572.0M | $189.2M | $147.7M | $122.4M |
| Liabilities | ||||||||
| Accounts Payable | $3.9M | $5.1M | $8.6M | $8.5M | $3.8M | $3.0M | $2.5M | $665.0K |
| Total Current Liabilities | $41.8M | $35.6M | $27.3M | $22.7M | $14.3M | $14.8M | $43.4M | $4.1M |
| Long-Term Debt | — | — | — | — | — | — | $10.9M | $15.0M |
| Total Liabilities | $51.4M | $43.2M | $36.9M | $32.6M | $22.0M | $17.8M | $55.7M | $19.1M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-1.25B | $-899.5M | $-665.1M | $-482.7M | $-357.4M | $-278.5M | $-249.7M | $-207.9M |
| Total Stockholders' Equity | $581.8M | $754.9M | $927.9M | $721.5M | $550.0M | $171.4M | $92.0M | $103.3M |